Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model

• Published in: The Journal of neuroscience Vol. 35; no. 2; pp. 688 - 706
• Main Authors: Arbour, Danielle, Tremblay, Elsa, Martineau, Éric, Julien, Jean-Pierre, Robitaille, Richard
• Format: Journal Article
• Language: English
• Published: United States Society for Neuroscience 14.01.2015
• Subjects: Amyotrophic Lateral Sclerosis - genetics; Amyotrophic Lateral Sclerosis - physiopathology; Animals; Calcium - metabolism; Mice; Neuromuscular Junction - metabolism; Neuromuscular Junction - physiopathology; Receptors, Muscarinic - metabolism; Schwann Cells - metabolism; Schwann Cells - physiology; Superoxide Dismutase - genetics; Superoxide Dismutase-1; Synaptic Potentials; muscarinic receptors; synaptic transmission; motor unit properties; perisynaptic Schwann cells; SOD1
• ISSN: 0270-6474; 1529-2401
• DOI: 10.1523/JNEUROSCI.1379-14.2015

Amyotrophic lateral sclerosis (ALS) is a late-onset neuromuscular disease characterized by progressive loss of motor neurons (MNs) preceded by neuromuscular junction (NMJ) denervation. Despite the importance of NMJ denervation in ALS, the mechanisms involved remain unexplored and ill defined. The contribution of glial cells in the disease has been highlighted, including axonal Schwann cell activation that precedes the decline of motor function and the onset of hindlimb paralysis. Because NMJ denervation occurs early in the process and that perisynaptic Schwann cells (PSCs), glial cells at the NMJ, regulate morphological stability, integrity, and repair of the NMJ, one could predict that PSC functions would be altered even before denervation, contributing to NMJ malfunctions. We tested this possibility using a slowly progressive model of ALS (SOD1(G37R) mice). We observed a normal NMJ organization at a presymptomatic stage of ALS (120 d), but PSC detection of endogenous synaptic activity revealed by intracellular Ca(2+) changes was enhanced compared with their wild-type littermates. This inappropriate PSC decoding ability was associated with an increased level of neurotransmitter release and dependent on intrinsic glial properties related to enhanced muscarinic receptor activation. The alteration of PSC muscarinic receptor functions also persists during the preonset stage of the disease and became dependent on MN vulnerability with age. Together, these results suggest that PSC properties are altered in the disease process in a manner that would be detrimental for NMJ repair. The impairments of PSC functions may contribute to NMJ dysfunction and ALS pathogenesis.